Page results
-
This week, clinical leaders across north central London have written to our local newspapers, outlining the rationale for temporary changes to children and young people's services across the region. The letter reflects on some of the lessons learnt from the first wave of the COVID-19 pandemic and the need to plan ahead for a likely second surge and a busy winter with all of the challenges that will bring. You can read the letter in full here:
-
This leaflet explains the support a transition coordinator at the Adolescent Rheumatology Department provides, and how they can help.
-
Information about energy conservation for UCLH patients with mitochondrial disease.
-
Advice on sleeping better for young people living with fatigue conditions.
-
Information for patients and visitors on patient isolation.
-
This information is for patients, (and their family and carers), who are considering having Uterine Artery (Fibroid) Embolisation (UAE). It explains what is involved and the possible risks.
-
It is important to make sure you are eating and drinking well before your surgery. Good nutrition will also help you recover after your surgery.
-
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
-
If your doctor has referred you for a blood test, please book your phlebotomy (blood test) appointment online in advance.
-
Patient information leaflet for Functional Electrical Stimulation (FES) Clinic
File results
-
FOI/2023/0648 - Robotic Process Automation (RPA)
-
FOI/2023/0649 - Maternity Information Systems (MIS)
-
FOI/2023/0651 - Professional nurse advocate
-
FOI/2023/0653 - Telecommunication pay as you go contract
-
FOI/2023/0654 - Email encryption/ E-signature suppliers
-
FOI/2023/0655 - Customer Relationship Management (CRM) system
-
FOI/2023/0658 - Policies/procedures for Non-emergency patient transport services
-
FOI/2023/0662 - NEPTS and patient transport services
-
FOI/2023/0665 - Trust pathology services
-
FOI/2023/0670 - Treatment with immunomodulatory medications